ReAlta Life Sciences
Dr. Krishna is a research scientist in virology and immunology. He completed his undergraduate degree in Biology with a minor in Chemistry at Earlham College in Richmond, Indiana followed by a PhD in Microbiology and Immunology from Pennsylvania State University, Hershey Medical Center where he studied retrovirus assembly. Dr. Krishna then went on to complete post-doctoral studies in viral structure and assembly at the Scripps Research Institute in La Jolla, California. Dr. Krishna is a Professor in the Department of Microbiology and Molecular Cell Biology and Department of Pediatrics at Eastern Virginia Medical School. His researchin virology and immunology have resulted in over 40 peer-reviewed research articles and multiple patents. He has been the Primary Investigator on 12 research grant awards and a Co-Investigator on 10 additional grant awards. He is the co-inventor of the PIC1 platform.
This person is not in any offices
ReAlta Life Sciences
ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late, 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.